Renaissance BioScience - About the company
Renaissance BioScience is a series A company based in Vancouver (Canada), founded in 2013 by John Husnik and Maurice Boucher. It operates as a Developer of bioengineering technology for agriculture, food, health, and industrial markets. Renaissance BioScience has raised $5M in funding. The company has 524 active competitors, including 94 funded and 53 that have exited. Its top competitors include companies like Advanta, Tropic Biosciences and Phylos Bioscience.
Company Details
Developer of bioengineering technology for agriculture, food, health, and industrial markets. It creates products and solutions using whole organism and gene-targeted engineering. The technology benefits multiple industries, including biopesticides, animal wellness, bakery, coffee, alcoholic beverages, probiotics, nutritional supplements, flavors, fragrances, and biofuels.
- Website
- renaissancebioscience.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2013
Location
Vancouver, Canada
Stage
Series A
Total Funding
$5M in 3 rounds
Latest Funding Round
Investors
Ranked
9th among 524 active competitors
Employee Count
23 as on Jul 31, 2026
Sign up to download Renaissance BioScience's company profile
Renaissance BioScience's funding and investors
Renaissance BioScience has raised a total funding of $5M over 3 rounds. Its first funding round was on Jun 09, 2017. Its latest funding round was a Grant (prize money) round on Feb 09, 2024 for $*****. 1 investor participated in its latest round. Renaissance BioScience has 4 institutional investors.
Here is the list of recent funding rounds of Renaissance BioScience:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 09, 2024 | 6782070 | Grant (prize money) | 1249405 | 9998095 | 4446753 | 7378879 |
Nov 04, 2021 | 7021496 | Series A | 1940617 | 1084192 | 4507178 | 2320912 |
Jun 09, 2017 | 6380139 | Grant (prize money) | 5527643 | 4375907 | 6714894 |
View details of Renaissance BioScience's funding rounds and investors
Renaissance BioScience's founders and board of directors
Founder? Claim ProfileThe founders of Renaissance BioScience are John Husnik and Maurice Boucher. John Husnik is the CEO of Renaissance BioScience.
Here are the details of Renaissance BioScience's key team members:
- John Husnik: Co-Founder & CEO of Renaissance BioScience.
- Maurice Boucher: Former Co-Founder of Renaissance BioScience. Contact Info: 1 email address
View details of Renaissance BioScience's Founder profiles and Board Members
Renaissance BioScience's employee count trend
Renaissance BioScience has 23 employees as of Jul 26. Here is Renaissance BioScience's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Renaissance BioScience's Competitors and alternates
Top competitors of Renaissance BioScience include Advanta, Tropic Biosciences and Phylos Bioscience. Here is the list of Top 10 competitors of Renaissance BioScience, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Advanta 1989, Dubai (United Arab Emirates), Public | Developer of high-nutrition crops for sustainable agriculture | $400M | 72/100 | |
2nd | Tropic Biosciences 2016, Norwich (United Kingdom), Series C | Developer of gene editing technologies for improved tropical crop production | $179M | 68/100 | |
3rd | Phylos Bioscience 2014, Portland (United States), Series B | Developer of cannabis F1 hybrid seeds and natural THC products | $31.2M | 60/100 | |
4th | Computomics 2012, Tubingen (Germany), Series B | Provider of data analysis services for next-generation sequencing data for the crop science industry | $7.85M | 60/100 | |
5th | Feld.energy 2024, Pocking (Germany), Seed | Provider of agricultural solutions | $13.5M | 59/100 | |
6th | Developer of computational tools for pharmaceutical and agricultural industries | - | 58/100 | ||
7th | Bharat Krushi Seva 2021, Pune (India), Seed | Online platform offering information related to agriculture | $756K | 58/100 | |
8th | Pairwise 2017, Durham (United States), Series C | Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops | $155M | 57/100 | |
9th | Renaissance BioScience 2013, Vancouver (Canada), Series A | Developer of bioengineering technology for agriculture, food, health, and industrial markets | $5M | 57/100 | |
10th | Biographica 2022, London (United Kingdom), Seed | Computational Platform for gene discovery and editing | $9.5M | 57/100 |
Looking for more details on Renaissance BioScience's competitors? Click here to see the top ones
Renaissance BioScience's Investments and acquisitions
Renaissance BioScience has made no investments or acquisitions yet.
Reports related to Renaissance BioScience
Here is the latest report on Renaissance BioScience's sector:
News related to Renaissance BioScience
Media has covered Renaissance BioScience for a total of 3 events in the last 1 year, 1 of them has been about partnerships.
•
Renaissance BioScience Secures Mexican Patent for Novel RNA Production and Delivery TechnologyHITECH news articles•Dec 04, 2025•Renaissance BioScience
•
Renaissance BioScience and Biome Bioplastics Partner to Develop Next-Gen BioplasticsPackaging Strategies•Nov 18, 2025•Renaissance BioScience, Biome Bioplastics
•
Renaissance BioScience Receives Government of Canada Funding to Target Destructive Canola Flea Beetle Crop PestsHITECH news articles•Sep 09, 2025•Renaissance BioScience
•
Renaissance Bioscience’s yeast-powered solution takes on potato pestsAgroPages•Jul 30, 2024•Renaissance BioScience
•
Renaissance BioScience receive grant to progress yeast-based solutions for plant-based proteinsNutraceuticalbusinessreview•Feb 09, 2024•Renaissance BioScience, Cfin-Rcia
•
•
•
Renaissance BioScience Appoints Kenneth Judge to the Company's Board of DirectorsBusiness PR News•Sep 19, 2023•Renaissance BioScience
•
Renaissance BioScience Corp adds a Key Strategic Board AdvisorBusiness PR News•Aug 14, 2023•Renaissance BioScience
•
Renaissance BioScience Corp. Announces New Patents For Acrylamide-Reducing Yeast TechnologyBusiness PR News•Feb 23, 2022•Renaissance BioScience
Are you a Founder ?
FAQs about Renaissance BioScience
Explore our recently published companies
- Dialysis HQ - San Francisco based, Unfunded company
- FlexPlum - Warsaw based, 2024 founded, Unfunded company
- Arimidori - 2024 founded, Unfunded company